Ketamine Series

Objective

Funded by the Miller-Dwan and Essentia Health Duluth Clinic Foundations, this study aims to improve our understanding in response to ketamine treatment among patients diagnosed with treatment-resistant (refractory) depression. Michael Messer, a psychiatrist at Essentia Health, and Irina Haller are co-leads on this study. Research team includes Colleen Renier and Jeanette Palcher. For more information contact Irina Haller at 218-786-8185.

Disclosures:

None

For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.

Last Updated: 12/29/2015

Research Study Categories

  • Healthcare Delivery Studies

Specialty

  • Specialty Care
  • Behavioral & Mental Health
Contact
Irina Haller at 218-786-8185